Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Curr Med Sci. 2020 Oct;40(5):835-844. doi: 10.1007/s11596-020-2268-z. Epub 2020 Oct 29.
PKHD1 mutations are generally considered to cause autosomal recessive polycystic kidney disease (ARPKD). ARPKD is a rare disorder and one of the most severe conditions leading to end-stage renal disease in childhood. With the biallelic deletion mutation, patients have difficulty in surviving the perinatal period, resulting in perinatal or neonatal death. This study retrospectively analyzed patient characteristics, imaging characteristics, laboratory examinations and family surveys from 7 Chinese children with different PKHD1 gene mutations diagnosed by high-throughput sequencing from January 2014 to February 2018. Of the 7 children, there were 3 males and 4 females. Eight missense mutations, two frameshift mutations, two deletion mutations, and two intronic slicing mutations were identified. Six of the mutations have not previously been identified. In the literature search, we identified a total of 29 Chinese children with PKHD1 mutations. The missense mutation c.2507T>C in exon 24 was found in one patient in our study, and five patients with liver fibrosis but normal renal function were reported in the literature. The missense mutation c.5935G>A in exon 37 was found in two patients in our study and three cases in the literature. Four patients had renal failure at an age as young as 1 year of those five patients with the missense mutation c.5935G>A in exon 37. It was concluded that: (1) Kidney length more than 2-3 SDs above the mean and early-onset hypertension might be associated with PKHD1-associated ARPKD; (2) The more enlarged the kidney size is, the lower the renal function is likely to be; (3) c.5935G>A may be a hot spot that leads to early renal failure in Chinese children with PKHD1 mutations; (4) c.2507T>C may be a hot-spot mutation associated with hepatic lesions in Chinese children with PKHD1.
PKHD1 基因突变通常被认为导致常染色体隐性多囊肾病 (ARPKD)。ARPKD 是一种罕见疾病,也是导致儿童终末期肾病的最严重疾病之一。带有双等位基因缺失突变的患者在围产期难以存活,导致围产期或新生儿死亡。本研究回顾性分析了 7 例 2014 年 1 月至 2018 年 2 月通过高通量测序诊断为不同 PKHD1 基因突变的中国儿童患者的临床特征、影像学特征、实验室检查和家系调查。7 例患儿中,男 3 例,女 4 例。共发现 8 种错义突变、2 种移码突变、2 种缺失突变和 2 种内含子剪接突变,其中 6 种突变此前尚未报道。文献检索共发现 29 例中国 PKHD1 基因突变患儿。本研究中发现 1 例患者存在外显子 24 中的 c.2507T>C 错义突变,文献报道 5 例肝纤维化但肾功能正常的患者存在该突变。本研究中发现 2 例患者存在外显子 37 中的 c.5935G>A 错义突变,文献报道 3 例患者存在该突变。5 例携带 c.5935G>A 错义突变的患者中,有 4 例在 1 岁时就出现肾衰竭。研究得出结论:(1)肾脏长度超过平均值 2-3 个标准差且发病年龄较早可能与 PKHD1 相关的 ARPKD 有关;(2)肾脏越大,肾功能越可能下降;(3)c.5935G>A 可能是导致中国 PKHD1 基因突变患儿早期肾衰竭的热点突变;(4)c.2507T>C 可能是导致中国 PKHD1 基因突变患儿肝脏病变的热点突变。